S1211 Extraintestinal Manifestations in Inflammatory Bowel Disease: Frequency and Associated Risk Factors in the Nationwide Swiss IBD Cohort Study (SIBDCS)

2010 ◽  
Vol 138 (5) ◽  
pp. S-205
Author(s):  
Stephan R. Vavricka ◽  
Lionel Brun ◽  
Pierluigi Ballabeni ◽  
Valérie Pittet ◽  
Michael Manz ◽  
...  
2016 ◽  
Vol 150 (4) ◽  
pp. S43 ◽  
Author(s):  
Stephan R. Vavricka ◽  
Luc Biedermann ◽  
Gerhard Rogler ◽  
Ekaterina Safroneeva ◽  
Alain M. Schoepfer ◽  
...  

2014 ◽  
Vol 39 (8) ◽  
pp. 802-810 ◽  
Author(s):  
A. J. Panara ◽  
A. J. Yarur ◽  
B. Rieders ◽  
S. Proksell ◽  
A. R. Deshpande ◽  
...  

2011 ◽  
Vol 106 (1) ◽  
pp. 110-119 ◽  
Author(s):  
Stephan R Vavricka ◽  
Lionel Brun ◽  
Pierluigi Ballabeni ◽  
Valérie Pittet ◽  
Bettina Mareike Prinz Vavricka ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-5 ◽  
Author(s):  
William Gillespie ◽  
Neil Marya ◽  
Julien Fahed ◽  
Gregory Leslie ◽  
Krunal Patel ◽  
...  

Aim. To investigate the epidemiology and risk factors of Clostridium difficile infections (CDI) in patients with inflammatory bowel disease (IBD). Methods. This is a retrospective study of patients diagnosed with IBD. 1006 charts were screened and 654 patients met the inclusion criteria. Patients were divided into 2 cohorts based on the presence of prior diagnosis of CDI. Statistical analysis with Pearson’s chi-squared and two-sample t-test was performed. Results. The incidence of CDI among IBD patients was 6.7%. There was equal prevalence of CDI among Crohn’s disease (CD) (n=21, 49%) and ulcerative colitis (UC) (n=22, 51%). IBD patients acquired CDI at a mean age of 42.7 years, with 56% of infections acquired in the community and only 28% associated with healthcare. Only 30% of IBD patients with CDI had prior antibiotic use, and 16% had prior steroid use. IBD patients were significantly more likely to require biologic therapy (57% versus 37%, p<0.01) and have extraintestinal manifestations of IBD (43% versus 28%, p<0.02). Conclusions. IBD patients are more susceptible to CDI at a younger age and often lack traditional risk factors. IBD patients with at least one CDI were more likely to require biologic therapy and had greater rates of extraintestinal manifestations.


2017 ◽  
Vol 23 (7) ◽  
pp. 1174-1181 ◽  
Author(s):  
Stephan R. Vavricka ◽  
Martin Gubler ◽  
Claudine Gantenbein ◽  
Muriel Spoerri ◽  
Florian Froehlich ◽  
...  

2015 ◽  
Vol 148 (4) ◽  
pp. S-458-S-459
Author(s):  
Stephan R. Vavricka ◽  
Roman Rechner ◽  
Nicolas Fournier ◽  
Gerhard Rogler ◽  
Pierre F. Michetti ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document